Numbers

Bibliography of the person, including all types of documents, not only theses.

PhD theses (3)

1. Tina Roblek: Vloga kliničnega farmacevta pri obravnavi klinično pomembnih interakcij med zdravili pri bolnikih s srčnim popuščanjem
2. Nanča Čebron Lipovec: Metabolic profiles of patients with chronic obstructive pulmonary disease before and after rehabilitation
3. Daniel Omersa: Ocena epidemioloških značilnosti srčnega popuščanja v Sloveniji

BSc theses (3)

1. Petra Jančar: Analiza učinkovitosti klinične poti za zdravljenje z nizkomolekulskimi heparini v bolnišnici Golnik
2. Anja Nanut: Vpliv komorbidnosti in sočasnega zdravljenja z zdravili na urejenost antikoagulacijskega zdravljenja z varfarinom
3. Andreja Detiček: Vpliv bolnišnične obravnave na farmakoterapijo bolnikov s srčnim popuščanjem

Other documents (29)

1. Tim Kambič, Vedran Hadžić, Mitja Lainščak: Hemodynamic response to high- and low-load resistance exercise in patients with coronary artery disease
2. Tim Kambič, Nejc Šarabon, Vedran Hadžić, Mitja Lainščak: Objectively measured physical activity in patients with coronary artery disease
3. Živa Lavriša, Hristo Hristov, Maša Hribar, Barbara Koroušić-Seljak, Matej Gregorič, Urška Blaznik, Katja Zaletel, Adrijana Oblak, Joško Osredkar, Anita Kušar, Katja Žmitek, Mitja Lainščak, Igor Pravst: Dietary iron intake and biomarkers of iron status in Slovenian population
4. Tim Kambič, Nejc Šarabon, Mitja Lainščak, Vedran Hadžić: Combined resistance training with aerobic training improves physical performance in patients with coronary artery disease
5. Katja Čvan Trobec, Iztok Grabnar, Jurij Trontelj, Mitja Lainščak, Mojca Kerec Kos: Population pharmacokinetics of ramipril in patients with chronic heart failure
6. Luka Hiti, Tijana Markovič, Mitja Lainščak, Jerneja Farkaš-Lainščak, Emil Pal, Irena Mlinarič-Raščan: The immunopathogenesis of a cytokine storm
7. Luka Varda, Robert Ekart, Mitja Lainščak, Uroš Maver, Sebastjan Bevc: Clinical properties and non-clinical testing of mineralocorticoid receptor antagonists in in vitro cell models
8. Gregor Verček, Tjaša Furlan, Dalibor Gavrić, Mitja Lainščak, Jerneja Farkaš-Lainščak, Irena Ograjenšek, Petra Došenović Bonča, Borut Jug: Statins for secondary prevention in women with atherosclerotic vascular disease
9. Borut Jug, Zlatko Fras, Tjaša Furlan, Marko Novaković, Jerneja Tasič, Mitja Lainščak, Jerneja Farkaš-Lainščak, Dalibor Gavrić, Irena Ograjenšek, Petra Došenović Bonča: Uptake and effectiveness of outpatient vs. residential cardiac rehabilitation after myocardial infarction
10. David Žižek, Marta Cvijić, Mitja Lainščak: Pharmacotherapy post-cardiac resynchronization therapy
11. Luka Petravić, Kaja Gril Rogina, Rok Miklič, Mitja Lainščak, Tinkara Langus, Anže Žnidaršič, Andreja Kukec, Matej Strnad: Strategic PAD positioning
12. Mitja Lainščak, Tina Zupanič, Daniel Omersa, Ivan Eržen, Jerneja Farkaš-Lainščak: Prevalence of cachexia and outcomes in patients with chronic diseases
13. Anja Kokalj Palandačić, Saša Ucman, Dragan Kovačić, Brigita Novak Šarotar, Mitja Lainščak: Anxiety in patients referred for elective coronary angiography
14. Mitja Lainščak, Gianluigi Savarese: Real-world heart failure registries
15. Luka Čavka, Alessandro Laviano, Mitja Lainščak: Frailty in cancer
16. Stephan Haehling, Mitja Lainščak: Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency
17. Stefan D. Anker, Mitja Lainščak: Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
18. Piotr Ponikowski, Mitja Lainščak, Stefan D. Anker: Hospitalization of symptomatic patients with heart failure and moderate to severe functional mitral regurgitation treated with MitraClip
19. Irena Šarc, Ramon C. J. Langen, Harry Reinier Gosker, Mitja Lainščak: Calprotectin and sarcopenia in COPD: biomarker, bystander or target?
20. Lars H. Lund, Mitja Lainščak: Heart failure in Europe
21. Tim Kambič, Tadej Debevec, Mitja Lainščak: Can intermittent hypoxic conditioning enhance the benefits of standard long COVID-19 rehabilitation?
22. Amr Abdin, Mitja Lainščak: European Society of Cardiology quality indicators update for the care and outcomes of adults with heart failure
23. Nino Cmor, Eva Dora, Mitja Lainščak, Miha Tibaut: Polymicrobial purulent pericarditis and peritoneal effusion in an immunocompromised patient with Staphylococcus aureus bacteraemia
24. Gianluigi Savarese, Mitja Lainščak: How to tackle therapeutic inertia in heart failure with reduced ejection fraction
25. Stefan D. Anker, Mitja Lainščak: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial
26. Mahir Karakas, Tim Friede, Javed Butler, Khawaja M. Talha, Marius Placzek, Thomas Asendorf, Monika Diek, Anna Nosko, Adriane Stas, Stefan Kluge, Mitja Lainščak: Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial)
27. Klara Rebernik Grah, Mitja Lainščak, Jerneja Farkaš-Lainščak: General and disease-specific health literacy in patients with heart failure
28. Klara Rebernik Grah, Mitja Lainščak, Jerneja Farkaš-Lainščak: Translation, cultural adaptation and psychometric evaluation of the Slovene version of the Heart Failure-Specific Health Literacy Scale in patients with heart failure
29. Nino Cmor, Eva Dora, Martina Zitko, Tomaž Kocjan, Mitja Lainščak: An unusual cause of fatal pulmonary embolism